🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesHas anyone dealt with anti-thrombotic properties of glp-1 receptor activation?

Has anyone dealt with anti-thrombotic properties of glp-1 receptor activation?

rachel_ABQ Tue, Nov 18, 2025 at 5:17 PM 30 replies 1,490 viewsPage 1 of 6
This thread is more than 6 months old. Information may be outdated. Consider searching for more recent discussions.
rachel_ABQ
Member
178
890
Dec 2024
Albuquerque, NM
Nov 18, 2025 at 6:42 PM#1

How do you all handle has anyone dealt with anti-thrombotic properties?

Looking for practical tips, not theoretical. What does your actual routine look like? Step by step if possible.

I have tried what my doctor suggested but it is not working great.

23 10nick_newbie, DadBodDave, AmyNC_wife and 20 others
Reply Quote Save Share Report
mike_nyc
VIP Member
5,678
21,345
Nov 2023
New York
Online
Nov 18, 2025 at 6:59 PM#2
rachel_ABQ said:
Has anyone dealt with anti-thrombotic properties of glp-1 receptor activation?

Gonna push back on this one. Has anyone dealt with is not that straightforward in my experience. I have been on this for 12 months and the reality is messier than the trials suggest.

Don't get me wrong — the medication works. But cost accessibility is a real barrier. We should be honest about that.

6 16stefan_berlin, Dr.EM_Chicago, pete_RVA and 3 others
Reply Quote Save Share Report
VendorMark
Senior Member
3,456
14,567
Jan 2024
Texas
Online
Nov 18, 2025 at 7:16 PM#3
rachel_ABQ said:
Has anyone dealt with anti-thrombotic properties of glp-1 receptor activation?

This is exactly right. rachel_ABQ articulated what I have been trying to explain to my doctor for months. The Has anyone dealt with aspect is the most important factor.

24 4MarkLI_maint, Dr.PeteFamMed, claudia_zurich and 21 others
Reply Quote Save Share Report
Dr.LeslieOBGYN
Member
567
2,567
May 2024
Dallas, TX
Nov 18, 2025 at 7:33 PM#4

Clinical perspective on Has anyone dealt with anti-thrombotic:

I have managed ~150 patients on GLP-1 therapy and this topic comes up frequently. What the data shows — and what I see in practice — is that proper titration prevents most adverse events.

For this specific question, I would recommend: reviewing the relevant clinical guidelines.

Last edited: Nov 19, 2025 at 1:33 AM
15 23NicoleRaleigh, james_edin, FranDenver and 12 others
Reply Quote Save Share Report
DebRD_ATL
Senior Member
1,678
7,890
Feb 2024
Atlanta, GA
Nov 18, 2025 at 7:50 PM#5
VendorMark said:
This is exactly right

I respect VendorMark perspective but I think this oversimplifies things a bit. Re: Has anyone dealt with — the effect size varies considerably by population.

I am not saying VendorMark wrong entirely — just that the picture is more nuanced than a blanket statement. The SURMOUNT data specifically shows baseline BMI-dependent responses.

Last edited: Nov 18, 2025 at 11:50 PM
25 17HealthEcon_DC, PedsEndoPhilly, SleepDoc_PDX and 22 others
Reply Quote Save Share Report
1236

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register